Effects of ACE inhibitors on long-term outcome of renal transplant recipients: A randomized controlled trial

Transplantation

Volumn 95, Issue 6, 2013, Pages 889-895

  Paoletti, Ernesto ^a   Bellino, Diego ^a   Marsano, Luigina ^a   Cassottana, Paolo ^a   Rolla, Davide ^a   Ratto, Elena ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

ACE inhibitors; Cardiovascular events; Outcome; Renal transplantation

Indexed keywords

CREATININE; LISINOPRIL; CALCINEURIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DRUG DERIVATIVE; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG DOSE TITRATION; DRUG EFFECT; DRUG EFFICACY; FEMALE; FOLLOW UP; GRAFT FAILURE; GRAFT RECIPIENT; HEART ARRHYTHMIA; HEART INFARCTION; HUMAN; KIDNEY TRANSPLANTATION; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; NEW ONSET DIABETES AFTER TRANSPLANTATION; PERIPHERAL VASCULAR DISEASE; PREDICTION; PRIORITY JOURNAL; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE; TREATMENT DURATION; TREATMENT OUTCOME; BLOOD; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; DISEASE FREE SURVIVAL; DRUG ANTAGONISM; GRAFT SURVIVAL; METHODOLOGY; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL;

ADULT; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCINEURIN; CARDIOVASCULAR DISEASES; COHORT STUDIES; CREATININE; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; GRAFT SURVIVAL; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; PROPORTIONAL HAZARDS MODELS; TREATMENT OUTCOME;

MLCS; MLOWN;

EID: 84877609070     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3182827a43     Document Type: Article

References (25)

1. Yusuf S, Sleight P, Pogue J, et al. Effects of an angiotensin-converting- enzyme inhibitor, ramipril, on cardiovascular events in high risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000; 342: 145.
2. Jafar TH, Schmid CH, Landa M, et al. Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease: a meta-analysis of patient-level data. Ann Intern Med 2001; 135: 73.
3. Brenner BM, Cooper ME, de Zeeuw D, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001; 345: 861.
4. Kidney Disease Outcomes Quality Initiative (K/DOQI). K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis 2004; 43: S1.
5. Hiremath S, Fergusson D, Doucette S, et al. Renin angiotensin system blockade in kidney transplantation: a systematic review of the evidence. Am J Transplant 2007; 7: 2350.
6. Cross NB, Webster AC, Masson P, et al. Antihypertensives for kidney transplant recipients: systematic review and meta-analysis of randomized controlled trials. Transplantation 2009; 88: 7.
7. Hernandez D, Muriel A, Abraira V, et al. Renin-angiotensin system blockade and kidney transplantation: a longitudinal cohort study. Nephrol Dial Transplant 2012; 27: 417.
8. Heinze G, Mitterbauer C, Regele H, et al. Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation. J Am Soc Nephrol 2006; 17: 889.
9. Opelz G, Zeier M, Laux G, et al. No improvement of patient or graft survival in transplant recipients treated with angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers: a Collaborative Transplant Study report. J Am Soc Nephrol 2006; 17: 3257.
10. Hernández D, Lacalzada J, Salido E, et al. Regression of left ventricular hypertrophy by lisinopril after renal transplantation: role of ACE gene polymorphism. Kidney Int 2000; 58: 889.
11. Midtvedt K, Hartmann A, Foss A, et al. Sustained improvement of renal graft function for two years in hypertensive renal transplant recipients treated with nifedipine as compared to lisinopril. Transplantation 2001; 72: 1787.
12. Suwelack B, Kobelt V, Erfmann M, et al. Long-term follow-up of ACE-inhibitor versus A-blocker treatment and their effects on blood pressure and kidney function in renal transplant recipients. Transpl Int 2003; 16: 313.
13. Paoletti E, Cassottana P, Amidone M, et al. ACE inhibitors and persistent left ventricular hypertrophy after renal transplantation: a randomized clinical trial. Am J Kidney Dis 2007; 50: 133.
14. El Agroudy AE, Hassan NA, Foda MA, et al. Effect of angiotensin II receptor blockade on plasma levels of TGF-beta 1 and interstitial fi-brosis in hypertensive kidney transplant patients. Am J Nephrol 2003; 23: 300.
15. Phillip T, Martinez F, Geiger H, et al. Candesartan improves blood pressure control and reduces proteinuria in renal transplant recipients: results from SECRET. Nephrol Dial Transplant 2010; 25: 967.
16. Paoletti E, Cassottana P, Bellino D, et al. Left ventricular geometry and adverse cardiovascular events in chronic hemodialysis patients on prolonged therapy with ACE inhibitors. Am J Kidney Dis 2002; 40: 728.
17. Rigatto C, Parfrey P, Foley RN, et al. Congestive heart failure in renal transplant recipients: risk factors, outcomes, and relationship with ischemic heart disease. J Am Soc Nephrol 2002; 13: 1084.
18. Halimi JM, Laouad I, Buchler M, et al. Early low-grade proteinuria: causes, short-term evolution and long-term consequences in renal transplantation. Am J Transplant 2005; 5: 2281.
19. Halimi JM, Buchler M, Al-Najjar A, et al. Urinary albumin excretion and the risk of graft loss and death in proteinuric and non-proteinuric renal transplant recipients. Am J Transplant 2007; 7: 618.
20. Palmer BF. Renal dysfunction complicating the treatment of hypertension. N Engl J Med 2002; 347: 1256.
21. Shahin Y, Khan JA, Samuel N, et al. Angiotensin converting enzyme inhibitors effect on endothelial dysfunction: a meta-analysis of randomised controlled trials. Atherosclerosis 2011; 216: 7.
22. Opelz G, Dohler B. Treatment of kidney transplant recipients with ACEi/ARB and risk of respiratory tract cancer: a Collaborative Transplant Study report. Am J Transplant 2011; 11: 2483.
23. Sahn DJ, De Maria A, Kisslo J, et al. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978; 58: 1072.
24. Devereux RB, Alonso DR, Lutas EM, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necroscopy findings. Am J Cardiol 1986; 57: 450.
25. Zoccali C, Benedetto FA, Mallamaci F, et al. Prognostic impact of the indexation of left ventricular mass in patients undergoing dialysis. J Am Soc Nephrol 2001; 12: 2768.